title: Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis.
authors.forename: Maria
authors.initials: M
authors.lastname: Esposito
authors.forename: Rosita
authors.initials: R
authors.lastname: Saraceno
authors.forename: Caterina
authors.initials: C
authors.lastname: Schipani
authors.forename: Dely
authors.initials: D
authors.lastname: Di Marcantonio
authors.forename: Luca
authors.initials: L
authors.lastname: Bianchi
authors.forename: Sergio
authors.initials: S
authors.lastname: Chimenti
mesh_terms: D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination